MannKind (MNKD)
(Delayed Data from NSDQ)
$4.32 USD
+0.01 (0.23%)
Updated May 10, 2024 04:00 PM ET
After-Market: $4.32 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum D VGM
Brokerage Reports
0 items in cart
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 221 - 228 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
A good day for MannKind: done with FDA meeting, successful Type 1 diabetes Phase III trial
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
It''s a CRL but no need for new studies, no safety issues raised: bear story loses a lot of its punch.
Provider: RODMAN & RENSHAW, CO.
Analyst: SIMEONIDIS S